Myriad Genetics
MYGN
$14.20
Share price
-0.20%
Change (1 day)
-52.60%
Change (1 year)
Myriad Genetics (MYGN) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : C$0.46 Billion
According to Myriad Genetics's latest financial reports the company's total liabilities are C$0.46 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | C$0.46 B | -2.77% |
| 2023-12-31 | C$0.48 B | 13.49% |
| 2022-12-31 | C$0.42 B | -5.59% |
| 2021-12-31 | C$0.44 B | |
| 2020-06-30 | C$0.66 B | 6.81% |
| 2019-06-30 | C$0.62 B | 126.07% |
| 2018-06-30 | C$0.27 B | -51.98% |
| 2017-06-30 | C$0.57 B | 234.51% |
| 2016-06-30 | C$0.17 B | 32.54% |
| 2015-06-30 | C$0.12 B | 15.6% |
| 2014-06-30 | C$0.11 B | 41.25% |
| 2013-06-30 | C$79.13 M | 41.38% |
| 2012-06-30 | C$55.97 M | 31.4% |
| 2011-06-30 | C$42.59 M | 10.54% |
| 2010-06-30 | C$38.53 M | 3.08% |
| 2009-06-30 | C$37.38 M | -50.23% |
| 2008-06-30 | C$75.1 M | 101.43% |
| 2007-06-30 | C$37.28 M | 24.71% |
| 2006-06-30 | C$29.89 M | 4.84% |
| 2005-06-30 | C$28.51 M | 41.83% |
| 2004-06-30 | C$20.1 M | -22.81% |
| 2003-06-30 | C$26.04 M | -39.75% |
| 2002-06-30 | C$43.23 M | -12.41% |
| 2001-06-30 | C$49.36 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | C$4.00 B | 755.99% | 🇺🇸 USA |
 | C$5.05 B | 979.91% | 🇺🇸 USA |
 | C$31.25 M | -93.32% | 🇺🇸 USA |
 | C$1.90 B | 307.64% | 🇺🇸 USA |
 | C$48.02 B | 10,164.32% | 🇺🇸 USA |